Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease.

Chiesa PA, Cavedo E, Vergallo A, Lista S, Potier MC, Habert MO, Dubois B, Thiebaut de Schotten M, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI).

Alzheimers Dement. 2019 May 18. pii: S1552-5260(19)30077-9. doi: 10.1016/j.jalz.2019.03.006. [Epub ahead of print]

PMID:
31113760
2.

Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease.

Vergallo A, Mégret L, Lista S, Cavedo E, Zetterberg H, Blennow K, Vanmechelen E, De Vos A, Habert MO, Potier MC, Dubois B, Neri C, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI).

Alzheimers Dement. 2019 Jun;15(6):764-775. doi: 10.1016/j.jalz.2019.03.009. Epub 2019 May 18.

PMID:
31113759
3.

Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease.

Chapman RM, Gardner MN, Klorman R, Mapstone M, Porsteinsson AP, Antonsdottir IM, Kamalyan L.

Alzheimers Dement (Amst). 2018 Aug 30;10:604-614. doi: 10.1016/j.dadm.2018.08.002. eCollection 2018.

4.

Potential Metabolomic Linkage in Blood between Parkinson's Disease and Traumatic Brain Injury.

Fiandaca MS, Gross TJ, Johnson TM, Hu MT, Evetts S, Wade-Martins R, Merchant-Borna K, Bazarian J, Cheema AK, Mapstone M, Federoff HJ.

Metabolites. 2018 Sep 7;8(3). pii: E50. doi: 10.3390/metabo8030050.

5.

Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints.

Cavedo E, Chiesa PA, Houot M, Ferretti MT, Grothe MJ, Teipel SJ, Lista S, Habert MO, Potier MC, Dubois B, Hampel H; INSIGHT-preAD Study Group; Alzheimer Precision Medicine Initiative (APMI).

Alzheimers Dement. 2018 Sep;14(9):1204-1215. doi: 10.1016/j.jalz.2018.05.014. Epub 2018 Jul 7. Review.

PMID:
30201102
6.

Toward Reproducible Results from Targeted Metabolomic Studies: Perspectives for Data Pre-processing and a Basis for Analytic Pipeline Development.

Gross T, Mapstone M, Miramontes R, Padilla R, Cheema AK, Macciardi F, Federoff HJ, Fiandaca MS.

Curr Top Med Chem. 2018;18(11):883-895. doi: 10.2174/1568026618666180711144323. Review.

PMID:
29992885
7.

Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls.

Fiandaca MS, Mapstone M, Mahmoodi A, Gross T, Macciardi F, Cheema AK, Merchant-Borna K, Bazarian J, Federoff HJ.

PLoS One. 2018 Apr 20;13(4):e0195318. doi: 10.1371/journal.pone.0195318. eCollection 2018.

8.

Precision pharmacology for Alzheimer's disease.

Hampel H, Vergallo A, Aguilar LF, Benda N, Broich K, Cuello AC, Cummings J, Dubois B, Federoff HJ, Fiandaca M, Genthon R, Haberkamp M, Karran E, Mapstone M, Perry G, Schneider LS, Welikovitch LA, Woodcock J, Baldacci F, Lista S; Alzheimer Precision Medicine Initiative (APMI).

Pharmacol Res. 2018 Apr;130:331-365. doi: 10.1016/j.phrs.2018.02.014. Epub 2018 Feb 16. Review.

PMID:
29458203
9.

Systems healthcare: a holistic paradigm for tomorrow.

Fiandaca MS, Mapstone M, Connors E, Jacobson M, Monuki ES, Malik S, Macciardi F, Federoff HJ.

BMC Syst Biol. 2017 Dec 19;11(1):142. doi: 10.1186/s12918-017-0521-2. Review.

10.

Longitudinal Functional Brain Mapping in Supernormals.

Wang X, Ren P, Baran TM, Raizada RDS, Mapstone M, Lin F; Alzheimer’s Disease Neuroimaging Initiative.

Cereb Cortex. 2019 Jan 1;29(1):242-252. doi: 10.1093/cercor/bhx322.

PMID:
29186360
11.

Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.

Mehta KY, Wu HJ, Menon SS, Fallah Y, Zhong X, Rizk N, Unger K, Mapstone M, Fiandaca MS, Federoff HJ, Cheema AK.

Oncotarget. 2017 Aug 18;8(40):68899-68915. doi: 10.18632/oncotarget.20324. eCollection 2017 Sep 15.

12.

Identify a shared neural circuit linking multiple neuropsychiatric symptoms with Alzheimer's pathology.

Wang X, Ren P, Mapstone M, Conwell Y, Porsteinsson AP, Foxe JJ, Raizada RDS, Lin F; and the Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2019 Feb;13(1):53-64. doi: 10.1007/s11682-017-9767-y.

PMID:
28913718
13.

Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals.

Zhuang Y, Qiu X, Wang L, Ma Q, Mapstone M, Luque A, Weber M, Tivarus M, Miller E, Arduino RC, Zhong J, Schifitto G.

J Neurovirol. 2017 Oct;23(5):704-712. doi: 10.1007/s13365-017-0553-9. Epub 2017 Aug 8.

14.

Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.

Chapman BP, Benedict RHB, Lin F, Roy S, Porteinsson A, Szigeti K, Federoff H, Mapstone M.

Int J Geriatr Psychiatry. 2018 Feb;33(2):332-339. doi: 10.1002/gps.4748. Epub 2017 Jun 14.

PMID:
28612377
15.

Communicating mild cognitive impairment diagnoses with and without amyloid imaging.

Grill JD, Apostolova LG, Bullain S, Burns JM, Cox CG, Dick M, Hartley D, Kawas C, Kremen S, Lingler J, Lopez OL, Mapstone M, Pierce A, Rabinovici G, Roberts JS, Sajjadi SA, Teng E, Karlawish J.

Alzheimers Res Ther. 2017 May 4;9(1):35. doi: 10.1186/s13195-017-0261-y. Review.

16.

Personality and Performance in Specific Neurocognitive Domains Among Older Persons.

Chapman BP, Benedict RH, Lin F, Roy S, Federoff HJ, Mapstone M.

Am J Geriatr Psychiatry. 2017 Aug;25(8):900-908. doi: 10.1016/j.jagp.2017.03.006. Epub 2017 Apr 3.

17.

Biomarker validation: Methods and matrix matter.

Mapstone M, Cheema AK, Zhong X, Fiandaca MS, Federoff HJ.

Alzheimers Dement. 2017 May;13(5):608-609. doi: 10.1016/j.jalz.2016.11.004. Epub 2016 Dec 21. No abstract available.

PMID:
28010950
18.

What success can teach us about failure: the plasma metabolome of older adults with superior memory and lessons for Alzheimer's disease.

Mapstone M, Lin F, Nalls MA, Cheema AK, Singleton AB, Fiandaca MS, Federoff HJ.

Neurobiol Aging. 2017 Mar;51:148-155. doi: 10.1016/j.neurobiolaging.2016.11.007. Epub 2016 Nov 21.

19.

The cingulate cortex of older adults with excellent memory capacity.

Lin F, Ren P, Mapstone M, Meyers SP, Porsteinsson A, Baran TM; Alzheimer's Disease Neuroimaging Initiative.

Cortex. 2017 Jan;86:83-92. doi: 10.1016/j.cortex.2016.11.009. Epub 2016 Nov 19.

20.

Longitudinal Alteration of Intrinsic Brain Activity in the Striatum in Mild Cognitive Impairment.

Ren P, Lo RY, Chapman BP, Mapstone M, Porsteinsson A, Lin F; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2016 Jul 25;54(1):69-78. doi: 10.3233/JAD-160368.

Supplemental Content

Loading ...
Support Center